Home / You searched for Epidyolex
Ananda Pharma, now the leading force in pharmaceutical cannabis research in the UK, has announced that the former Chief Operating...
IM Cannabis IM Cannabis has become the latest major Israeli cannabis company to announce potential plans to depart the industry...
Jazz Pharmaceuticals has rebuffed attempts by rival Teva Pharmaceuticals to legally disqualify its patent for Epidyolex, a cannabis-based drug worth...
PRESS RELEASE JAZZ Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Epidyolex® (cannabidiol,100 mg/mL oral solution), developed by GW Pharmaceuticals...
Earlier this week, the first official guidance on medical cannabis for police officers in England and Wales was made public....
Findings from the successful trials of a new, multi-compound, cannabis medicine look set to deliver a major breakthrough for the...
Ananda Pharma, one of the UK’s leading clinical-stage pharmaceutical cannabis companies, has announced a string of strategic pivots, including stepping...
The European medical cannabis industry is continuing to mature, seeing companies focused on science-based research push the boundaries of our...
German pharmaceutical company Vertanical believes it is on course to deliver the first ‘whole-plant’, cannabis medicine with international approval. After...
Nachfolgend haben wir im zweiten Teil die wichtigsten Erkenntnisse aus den lebhaften und vielfältigen Diskussionen von Tag 1 der Cannabis...
THE latest move by the French authorities to undermine the country’s thriving CBD industry will be met with widespread resistance,...
Ananda Pharma [stock_market_widget type=”chart” template=”line” assets=”ANANF” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Just days after...